Ads
related to: drug companies- Learn More
Learn About Xifaxan® (rifaximin)
As A Treatment Option.
- Patient Stories
Hear From Real Patients Experience
With Xifaxan® (rifaximin).
- Resources & Support
Browse Our Resources & Information.
View The Doctor Discussion Guide.
- Healthcare Professionals
Obtain Product Information
Relevant To Your Patients.
- Learn More
Search results
People who use weight loss drugs like Ozempic face a problem: What to do when they run out or can't...
INSIDER via Yahoo News· 14 hours agoBut the single study used a small sample size, indicating that more research is needed to confirm...
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar via Yahoo News· 19 hours agoHealthcare. Almost a dozen pharmaceutical companies, including several major players, have lost...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 27 minutes agoThe US Food and Drug Administration (FDA) has accepted for priority review Sanofi's supplemental...
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a...
Motley Fool via Yahoo Finance· 24 minutes agoSeigerman recently noted that soaring demand for Eli Lilly's weight management drug, Zepbound, is...
Drug companies pay doctors over A$11 million a year for travel and education - EconoTimes
EconoTimes· 4 days agoDrug companies are paying Australian doctors millions of dollars a year to fly to overseas...
BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
Endpoints News· 45 minutes agoIt’s going back to MediLink Therapeutics for antibody-drug conjugates in a new deal that begins with...
Major drug companies caught up in Cencora data loss
The Register· 1 day agoMore than a dozen big pharmaceutical suppliers have begun notifying individuals that their data was stolen when US drug wholesaler Cencora was breached...
...Thinks It's Possible To Meet BofA's $60B Revenue Projection From New Drug Launches - Eli Lilly...
Benzinga· 2 hours agoDavid Ricks, CEO of Eli Lilly and Co LLY, expressed confidence in meeting the lofty revenue...
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 6 days agoThe bank initiated coverage of the near-$2 billion biotech company with an "Overweight" rating and...
Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion
Reuters· 2 hours ago, opens new tab for about 11.8 billion Swedish crowns ($1.1 billion) as part of a plan to become a...
Ad
related to: drug companies